Implantica presents the third quarter 2024 on November 15 at 15:00 CEST

VADUZ, Liechtenstein, Nov. 8, 2024 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the third quarter 2024 at 15:00 CET on November 15. The interim report for the third quarter will be published at 8:00 a.m. CET on the same day.

The presentation will be in English via an audiocast with teleconference:

If you wish to participate via webcast, please use the following link:

• https://ir.financialhearings.com/implantica-q3-report-2024

If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the conference.

• https://conference.financialhearings.com/teleconference/?id=50049903

Speakers:

• CEO Peter Forsell
• CFO Andreas Öhrnberg
• Chief Corporate Affairs Officer Nicole Pehrsson

For further information, please contact:Nicole Pehrsson, Investor RelationsTelephone (CH): +41 (0)79 335 09 [email protected]

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company's Certified Adviser is FNCA Sweden AB, [email protected]

The information was sent for publication, through the agency of the contact person set out above, on November 8, 2024 at 11:50 a.m. CET.

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/implantica/r/implantica-presents-the-third-quarter-2024-on-november-15-at-15-00-cest,c4063573

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/implantica-presents-the-third-quarter-2024-on-november-15-at-1500-cest-302299862.html